Plus de 40 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
An Integrated European ‘Flagship’ Program Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st Century (EU-ToxRisk)
Date du début: 1 janv. 2016, Date de fin: 31 déc. 2021,
The vision of EU-ToxRisk is to drive a paradigm shift in toxicology towards an animal-free, mechanism-based integrated approach to chemical safety assessment. The project will unite all relevant disciplines and stakeholders to establish: i) pragmatic, solid read-across procedures incorporating mechanistic and toxicokinetic knowledge; and ii) ab initio hazard and risk assessment strategies of chemi...
Voir le projet
43
Participants partenaires
TERMINÉ
European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates (EHVA)
Date du début: 1 janv. 2016, Date de fin: 31 déc. 2020,
Many HIV vaccine concepts and several efficacy trials have been conducted in the prophylactic and therapeutic fields with limited success. There is an urgent need to develop better vaccines and tools predictive of immunogenicity and of correlates of protection at early stage of vaccine development to mitigate the risks of failure. To address these complex and challenging scientific issues, the Eur...
Voir le projet
43
Participants partenaires
TERMINÉ
An integrated interdisciplinary approach to animal-free chemical and nanomaterial safety assessment (in3)
Date du début: 1 janv. 2017, Date de fin: 31 déc. 2020,
All chemicals whether they are drugs, cosmetics, agrochemicals or others need to be tested for their safety to man and the environment. The use of whole animal studies for the prediction of adverse effects in man, is problematic due to species dependent effects, high costs and a large burden to animals in terms of numbers and suffering. While there have been major improvements in human in vitro a...
Voir le projet
14
Participants partenaires
TERMINÉ
The artificial pancreas in children aged 1 to 7 years with type 1 diabetes (KidsAP)
Date du début: 1 janv. 2017, Date de fin: 30 juin 2020,
TYPE 1 DIABETES is one of the most COMMON CHRONIC diseases in children with a RAPID increase in number of cases particularly in young children. Type 1 diabetes is associated with LIFE-LONG dependency on insulin administration. POOR glucose control leads to diabetes COMPLICATIONS, e.g. eye, heart, kidney disease, including BRAIN changes in young children. Episodes of VERY LOW glucose levels may be ...
Voir le projet
14
Participants partenaires
TERMINÉ
Providing the right care to the right patient with MyeloDysplastic Syndrome at the right time (MDS-RIGHT)
Date du début: 1 mai 2015, Date de fin: 30 avr. 2020,
Myelodysplastic syndromes (MDS) are chronic bone marrow malignancies of the elderly, complicated by severe anaemia. MDS significantly affects quality-adjusted survival and it imposes an increasing financial burden on patients and healthcare (HC) systems. The burden of disease is expected to worsen in the future, given the aging EU population and newly identified MDS cases among those diagnosed wit...
Voir le projet
16
Participants partenaires
TERMINÉ
Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone (FAIR-PARK-II)
Date du début: 1 mai 2015, Date de fin: 30 avr. 2020,
Parkinson’s disease (PD) is a major, chronic, non-communicable disease and the 2nd most frequent neurodegenerative disorder worldwide. Excess iron is primarily detected in the substantia nigra pars compacta, where dopaminergic neurons are exposed to high levels of oxidative stress produced by mitochondrial disorders and dopamine metabolism. Our previous preclinical, translational and pilot clinica...
Voir le projet
17
Participants partenaires
TERMINÉ
Development of Biomaterial-based Delivery Systems for Parkinson’s disease - an Integrated Pan-European Approach (BrainMatTrain)
Date du début: 1 janv. 2016, Date de fin: 31 déc. 2019,
BrainMatTrain focuses on a comprehensive understanding of Parkinson’s disease (PD), from basics to translation, fully supported by 8 full partners partner organisation (4 research institutions, 2 hospitals, 2 SMEs) and one partner organisation (SME specialist in device design). This ETN will educate and train 15 Earlty Stage Researchers (ESRs) in functioanlised biomaterials, materials science, fun...
Voir le projet
8
Participants partenaires
TERMINÉ
OpenRiskNet: Open e-Infrastructure to Support Data Sharing, Knowledge Integration and in silico Analysis and Modelling in Risk Assessment (OpenRiskNet)
Date du début: 1 déc. 2016, Date de fin: 30 nov. 2019,
Toxicology and risk assessment are undergoing a paradigm shift, from a phenomenological to a mechanistic discipline based on in vitro and in silico approaches that represent an important alternative to classical animal testing applied to the evaluation of chronic and systemic toxicity risks. Large databases and highly sophisticated methods, algorithms and tools are available for different tasks su...
Voir le projet
14
Participants partenaires
TERMINÉ
Training Network for the Immunotherapy of Cancer (IMMUTRAIN)
Date du début: 1 déc. 2015, Date de fin: 30 nov. 2019,
In the European Union, cancer is the leading cause of death and the overall cancer incidence is still increasing. As a result of expanding efforts to improve cancer outcome, a main paradigm change is occurring in cancer therapy towards individualized medicine. Antibody-based therapies form an integral and constantly growing part of this approach. Antibody-based therapies will strongly influence th...
Voir le projet
9
Participants partenaires
TERMINÉ
From Omics to Patient: Improving Diagnostics of Pathogenic Yeasts (OPATHY)
Date du début: 1 sept. 2015, Date de fin: 31 août 2019,
OPATHY is an innovative translational research training network that will explore the potential of omics technologies, including genomics, transcriptomics and proteomics, to study the interactions of yeasts that cause disease to humans (e.g. Candida and Cryptococcus sp.) with their host, and to develop new diagnostic tools to monitor yeast infections in the clinic. Today, these infections are poor...
Voir le projet
10
Participants partenaires
TERMINÉ
A drug strategy targeting stabilised mutant p53 to fight metastatic platinum-resistant ovarian cancer (GANNET53)
Date du début: 1 oct. 2013, Date de fin: 31 mars 2019,
"Epithelial ovarian cancer (EOC) is the most lethal gyncaecological malignancy causing 41900 deaths annually in Europe. The predominance of aggressive Type II tumours, which are characterised by a high frequency of p53 mutations, and primary or acquired resistance to platinum-based chemotherapy profoundly contribute to the high mortality rate. With current standard therapy the median overall survi...
Voir le projet
20
Participants partenaires
TERMINÉ
Diagnostic Imaging Strategies for Patients with Stable Chest Pain and Intermediate Risk of Coronary Artery Disease: Comparative Effectiveness Research of Existing Technologies (DISCHARGE)
Date du début: 1 févr. 2014, Date de fin: 31 janv. 2019,
Coronary artery disease (CAD) is the leading cause of death in high-income countries. Invasive coronary angiography (ICA) is the reference standard for the diagnosis of CAD and allows immediate therapy. However, only 40% of patients undergoing ICA actually have obstructive CAD and ICA has relatively rare but considerable risks. Coronary computed tomography (CT) is the most accurate diagnostic test...
Voir le projet
38
Participants partenaires
TERMINÉ
Multimodal Imaging of rare Synucleinopathies (MultISyn)
Date du début: 1 oct. 2013, Date de fin: 30 sept. 2018,
Despite remarkable progress in the understanding of the molecular pathogenesis of neurodegenerative diseases (NDD), no causative or disease-modifying treatment is currently available. Aggregation of misfolded proteins are thought to play a crucial role in the pathogenesis, but attempts to exploit this knowledge for novel treatments have not been successful. Also, pathogenetically relevant biomarke...
Voir le projet
9
Participants partenaires
TERMINÉ
Health Care Work Exchange 2016
Date du début: 1 juin 2016, Date de fin: 31 mai 2018,
The “Health Care Work Exchange 2016” project will enable 100 apprentices and students of health care vocational schools from 1 June 2016 to 31 May 2018 to carry out an internship in all countries participating in the ERASMUS+ Mobility Program. Apprentices and students in the fields of nursing, midwifery, physical therapy, occupational therapy, speech therapy, special education and in medical techn...
Voir le projet
39
Participants partenaires
TERMINÉ
APERIM: Advanced bioinformatics platform for PERsonalised cancer IMmunotherapy (APERIM)
Date du début: 1 mai 2015, Date de fin: 30 avr. 2018,
Cancer treatment platforms that involve the use of the adaptive immune system have demonstrated profound tumour regressions including complete cure. Importantly, technological advances in next-generation sequencing (NGS) allow for the first time the development of personalised cancer immunotherapies that target patient specific mutations. However, clinical application is currently hampered by spec...
Voir le projet
11
Participants partenaires
TERMINÉ
Human Brain Project Specific Grant Agreement 1 (HBP SGA1)
Date du début: 1 avr. 2016, Date de fin: 31 mars 2018,
Understanding the human brain is one of the greatest scientific challenges of our time. Such an understanding can provide profound insights into our humanity, leading to fundamentally new computing technologies, and transforming the diagnosis and treatment of brain disorders. Modern ICT brings this prospect within reach. The HBP Flagship Initiative (HBP) thus proposes a unique strategy that uses I...
Voir le projet
126
Participants partenaires
TERMINÉ
European Clinical Research Infrastructures Network - Integrating Activity (ECRIN-IA)
Date du début: 1 janv. 2012, Date de fin: 31 déc. 2017,
ECRIN is a distributed ESFRI-roadmap pan-European infrastructure designed to support multinational clinical research, making Europe a single area for clinical studies, taking advantage of its population size to access patients. Servicing multinational trials started during its preparatory phase, and it now applies for an ERIC status by 2011. The ERIC budget will be restricted to core activities re...
Voir le projet
48
Participants partenaires
TERMINÉ
Higher education student and staff mobility project
Date du début: 1 juin 2016, Date de fin: 30 sept. 2017,
This is a higher education student and staff mobility project, please consult the website of the organisation to obtain additional details.
Voir le projet
1
Participant partenaire
TERMINÉ
Non-coding RNAs in neurogenic and neuropathic pain mechanisms and their application for risk assessment, patient stratification and personalised pain medicine (NCRNAPAIN)
Date du début: 1 oct. 2013, Date de fin: 30 sept. 2017,
Neuro-immune alterations in the peripheral and central nervous system play a role in the pathophysiology of chronic pain, and non-coding RNAs (ncRNAs) regulate both immune and neuronal processes. Therefore, ncRNAPain proposes that ncRNAs are critically important master switches for chronic pain.ncRNAPain represents a multidisciplinary consortium of clinical partners, molecular and systems-level n...
Voir le projet
12
Participants partenaires
TERMINÉ
Reach α-synuclein-dependent neurodegeneration: clinical development of therapeutic AFFITOPE vaccines for Parkinson’s disease and multisystem atrophy (SYMPATH)
Date du début: 1 oct. 2013, Date de fin: 30 sept. 2017,
The goal of SYMPATH is to advance clinical development of therapeutic vaccines targeting α-synuclein (aSyn)-driven neurodegenerative diseases (ND). It addresses Parkinson’s disease (PD) and multiple system atrophy (MSA), two synucleopathies, for which no causal therapy exists. Ultimately, both lead to patient disability and death, which along with patient number (PD) and age of onset (MSA, PD) def...
Voir le projet
8
Participants partenaires
TERMINÉ
Stem cells for Biological Assays of Novel drugs and prediCtive toxiCology (StemBANCC) (STEMBANCC)
Date du début: 1 oct. 2012, Date de fin: 30 sept. 2017,
StemBANCC, comprising internationally renowned investigators, is ideally positioned to deliver a unique European biorepository and drug discovery pipeline based upon human induced pluripotent stem cells (hiPSC). This unrivalled opportunity will address the pressing therapeutic need in neurodegeneration, neurodysfunction and diabetes. We have immediate access to richly phenotyped subjects with a we...
Voir le projet
38
Participants partenaires
TERMINÉ
Closed-loop Molecular Environment for Minimally Invasive Treatment of Patients with metastatic Gastrointestinal Stromal Tumours (MITIGATE)
Date du début: 1 oct. 2013, Date de fin: 30 sept. 2017,
Gastrointestinal stromal tumours (GIST) are a rare disease that metastasises in up to 85% of patients with subsequent median progression-free survival (PFS) of only around 30 months. Tumours are characterised by activating mutations in the KIT or the PDGFRA gene and therefore treatment is mainly based on tyrosine kinase inhibitors designed to block these mutated receptors. However, drug resistance...
Voir le projet
10
Participants partenaires
TERMINÉ
VitaminD3-Omega3-Home Exercise- HeALTHy Ageing and Longevity Trial (DO-HEALTH)
Date du début: 1 janv. 2012, Date de fin: 30 juin 2017,
As the European population is ageing rapidly, the growing number of seniors with age-related chronic diseases poses a challenge on European societies and health care systems. Therapeutic interventions that are effective, affordable and well-tolerated in the prevention of chronic disease are urgently needed and will have an outstanding impact on public health as a whole. Among the most promising in...
Voir le projet
25
Participants partenaires
TERMINÉ
Health Care Work Exchange 2015
Date du début: 1 juin 2015, Date de fin: 31 mai 2017,
From 1.6.2015 to 31.5.2017 the project “Health Care Work Exchange 2015” will offer 100 apprentices and students of health care vocational schools an opportunity to carry out an internship in all countries participating in ERASMUS+. Foremost apprentices and students in the fields of nursing, midwifery, physical therapy, occupational therapy, speech therapy, special education and in medical technica...
Voir le projet
38
Participants partenaires
TERMINÉ
Anti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the risk (ABIRISK)
Date du début: 1 mars 2012, Date de fin: 28 févr. 2017,
The ABIRISK project provides an integrated approach to the study of immunization against biopharmaceuticals, bringing together a unique panel of experts from different disciplines. ABIRISK will involve many of the European leaders in rheumatology, gastroenterology, hemophilia and multiple sclerosis, caring for ~30,000 patients treated with biopharmaceuticals, with ~10,000 additional patients recru...
Voir le projet
39
Participants partenaires
TERMINÉ
European multicentre, randomised, phase III clinical trial of hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke (EuroHYP-1)
Date du début: 1 févr. 2012, Date de fin: 31 janv. 2017,
The consortium led by UKER and EuroHYP, the European Stroke Research Network for Hypothermia, proposes a large, multicentre clinical trial which will assess mild hypothermia as a novel treatment for ischemic stroke.Stroke is the second cause of death world-wide and the second cause of lost disability-adjusted life years in high-income countries. Stroke incidence rises exponentially with age, so it...
Voir le projet
38
Participants partenaires
TERMINÉ
EUROPEAN FORENSIC GENETICS Network of Excellence (EUROFORGEN-NOE)
Date du début: 1 janv. 2012, Date de fin: 31 déc. 2016,
The EUROFORGEN-NoE proposal aims to develop a network of excellence for the creation of a European Virtual Centre of Forensic Genetic Research. Forensic genetics is a highly innovative field of applied science with a strong impact on the security of citizens. However, the genetic methods to identify offenders as well as the creation of national DNA databases have caused concerns to the possible vi...
Voir le projet
19
Participants partenaires
TERMINÉ
Higher education student and staff mobility project
Date du début: 1 juin 2015, Date de fin: 30 sept. 2016,
This is a higher education student and staff mobility project, please consult the website of the organisation to obtain additional details.
Voir le projet
1
Participant partenaire
TERMINÉ
The Human Brain Project (HBP)
Date du début: 1 oct. 2013, Date de fin: 30 sept. 2016,
Understanding the human brain is one of the greatest challenges facing 21st century science. If we can rise to the challenge, we can gain profound insights into what makes us human, develop new treatments for brain diseases and build revolutionary new computing technologies. Today, for the first time, modern ICT has brought these goals within sight. The goal of the Human Brain Project, part of the...
Voir le projet
116
Participants partenaires
TERMINÉ
OPtimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) (OPTiMiSE)
Date du début: 1 févr. 2010, Date de fin: 31 juil. 2016,
OPTiMiSE (OPtimization of Treatment and Management of Schizophrenia in Europe) will focus on two goals: optimising current treatments in Schizophrenia and explore novel therapeutic options for schizophrenia. The project intends to both address basic, but so far unanswered, questions in the treatment of schizophrenia and develop new and experimental interventions. It is expected that the project wi...
Voir le projet
25
Participants partenaires
TERMINÉ
Demonstrating Minicare, a miniaturized biophotonics platform for fast and lab-equivalent Point-of-Care diagnostics (Lab2Go)
Date du début: 1 janv. 2014, Date de fin: 30 juin 2016,
To speed up the availability of cTnI test results (for heart attack indications), a highly integrated, biophotonics based, handheld-device is currently developped by a number of European based companies (Philips, Conworx Technology, Micro Systems Limited and Scienion AG) : Minicare. This device can be used at the patients' bed side by nurses and physicians as well as in ambulances and provides re...
Voir le projet
10
Participants partenaires
TERMINÉ
Health Care Work Exchange 2014
Date du début: 1 juin 2014, Date de fin: 31 mai 2016,
From 1.6.2014 to 31.5.2016 the project “Health Care Work Exchange 2014” will offer 100 apprentices and students of health care vocational schools an opportunity to carry out an internship in all countries participating in ERASMUS+. Foremost apprentices and students in the fields of nursing, midwifery, physical therapy, occupational therapy, speech therapy, special education and in medical technica...
Voir le projet
27
Participants partenaires
TERMINÉ
Detection of endpoints and biomarkers of repeated dose toxicity using in vitro systems (DETECTIVE)
Date du début: 1 janv. 2011, Date de fin: 31 déc. 2015,
"Assessment of repeated dose toxicity is a standard requirement in human safety evaluation and relies on animal testing as no alternatives are currently accepted for regulatory purposes. An integrated research strategy for the replacement of animal tests needs to comprise the development of biomarkers of long-term toxicity in human target cells. To this aim, the DETECTIVE project will set up a scr...
Voir le projet
15
Participants partenaires
TERMINÉ
EUROpean consortium for antiCALINs as next generation high-affinity protein therapeutics (EUROCALIN)
Date du début: 1 août 2011, Date de fin: 30 nov. 2015,
The consortium aims to develop and produce an Anticalin, a member of a novel high-affinity scaffold derived from the lipocalin protein family. The Anticalin is specific for hepcidin which is a central regulator of iron homeostasis, and will be used to antagonize hepcidin for the treatment of “anemia of chronic disease” (ACD). Anticalins are genetically modified lipocalins that can target almost an...
Voir le projet
11
Participants partenaires
TERMINÉ
Higher education student and staff mobility project
Date du début: 1 juin 2014, Date de fin: 30 sept. 2015,
The internationality of teaching and research is particularly important to the Medical University of Innsbruck. Providing students, lecturers, and staff with the opportunity to gain international experience and acquire intercultural skills plays a key role in qualifying them for international competition. Our long-standing participation in the Erasmus programme is a very important aspect. In this...
Voir le projet
1
Participant partenaire
TERMINÉ
Language learning in monolingual and bilingual infants: Evidence from electrophysiological and optical signals (InfantBilingualBrain)
Date du début: 1 juil. 2013, Date de fin: 30 juin 2015,
Bilingual infants have to deal with two languages at the same time. Some previous studies showed delayed processing in bilinguals due to the higher cognitive load they are faced with. However, other studies show that they master this challenging task with a fascinating ease and at the same pace as monolingual infants. In order to get clearer insights into language learning processing mechanisms in...
Voir le projet
1
Participant partenaire
TERMINÉ
Coherently Advanced Tissue and Cell Holographic Imaging and Trapping (CATCHIT)
Date du début: 1 mai 2010, Date de fin: 30 avr. 2015,
We envisage a new generation of dynamic holographic laser tweezers and stretching tools with unprecedented spatial control of gradient and scattering light forces, to unravel functional mysteries of cell biology and genetics: Based on our recently developed, highly successful and widely recognized amplitude and phase shaping techniques with cascaded spatial light modulators (SLM), we will create n...
Voir le projet
1
Participant partenaire
TERMINÉ
European Friedreich's Ataxia Consortium for Translational Studies (EFACTS)
Date du début: 1 mai 2010, Date de fin: 30 avr. 2015,
EFACTS (the European Friedreich’s Ataxia Consortium for Translational Studies) assembles a body of expertise to adopt a translational research strategy for the rare autosomal recessive neurological disease, Friedreich’s ataxia (FRDA). FRDA is a severely debilitating disease that leads to loss of the ability to walk and dependency for all activities. Some patients have cardiomyopathy that can cause...
Voir le projet
15
Participants partenaires
TERMINÉ
Construction kit for tailor-made vascularized boneimplants (VascuBone)
Date du début: 1 janv. 2010, Date de fin: 31 mars 2015,
The goal of VascuBone is to develop a “tool box” for bone regeneration, which on one hand fulfils basic requirements and on the other hand is freely combinable with what is needed in the respective patient’s situation. The tool box will include a variation of biocompatible biomaterials and cell types, FDA approved growth factors, material modification technologies, simulation and analytical tools ...
Voir le projet
18
Participants partenaires
TERMINÉ
OPtimizing TArgets and Therapeutics In high risk and refractOry Multiple Myeloma (OPTATIO)
Date du début: 1 janv. 2012, Date de fin: 31 mars 2015,
Multiple Myeloma (MM) is an incurable disease with rapidly growing prevalence and poor prognosis. Consequently, it is the goal of the OPTATIO consortium to seek out novel strategies for the development of novel diagnostic and therapeutic options. The MM pathogenesis involves not only genetic changes within the tumour cells but also the emergence of supportive conditions by the bone marrow microenv...
Voir le projet